Publicaciones en las que colabora con ÁNGEL VICENTE DELGADO MORA (54)

2022

  1. Combined Magnetic Hyperthermia and Photothermia with Polyelectrolyte/Gold-Coated Magnetic Nanorods

    Polymers, Vol. 14, Núm. 22

2021

  1. Amphiphilic-like carbon dots as antitumoral drug vehicles and phototherapeutical agents

    Materials Chemistry Frontiers, Vol. 5, Núm. 23, pp. 8151-8160

  2. Aplicación de nanocompuestos core/shell (Fe3O4/PCL) en fototerapia antitumoral

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 162-163

  3. Poly(Ethylene-imine)-functionalized magnetite nanoparticles derivatized with folic acid: Heating and targeting properties

    Polymers, Vol. 13, Núm. 10

2020

  1. First steps in the formulation of praziquantel nanosuspensions for pharmaceutical applications

    Pharmaceutical Development and Technology, Vol. 25, Núm. 7, pp. 892-898

  2. Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer

    Polymers, Vol. 12, Núm. 12, pp. 1-17

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497

2017

  1. Design and characterization of a magnetite/PEI multifunctional nanohybrid as non-viral vector and cell isolation system

    International Journal of Pharmaceutics, Vol. 518, Núm. 1-2, pp. 270-280

  2. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs

    AAPS PharmSciTech, Vol. 18, Núm. 8, pp. 3042-3052

  3. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

    International Journal of Pharmaceutics, Vol. 516, Núm. 1-2, pp. 61-70

  4. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

2015

  1. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444

2014

  1. Particle geometry, charge, and wettability: The fate of nanoparticle-based drug vehicles. The fate of nanoparticle-based drug vehicles.

    Colloid and Interface Science in Pharmaceutical Research and Development (Elsevier Inc.), pp. 443-467

2011

  1. Engineering of an antitumor (core/shell) magnetic nanoformulation based on the chemotherapy agent ftorafur

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 384, Núm. 1-3, pp. 157-163

2010

  1. Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting

    Colloids and Surfaces B: Biointerfaces, Vol. 77, Núm. 1, pp. 111-116

  2. Organoclay particles as reinforcing agents in polysaccharide films

    Journal of Colloid and Interface Science, Vol. 347, Núm. 1, pp. 74-78

2009

  1. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment

    International Journal of Pharmaceutics, Vol. 382, Núm. 1-2, pp. 270-276

  2. Kollidon® SR colloidal particles as vehicles for oral morphine delivery in pain treatment

    Colloids and Surfaces B: Biointerfaces, Vol. 70, Núm. 2, pp. 207-212

  3. Study of the stability of Kollidon® SR suspensions for pharmaceutical applications

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 338, Núm. 1-3, pp. 107-113